Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Prog Cardiovasc Dis ; 76: 49-56, 2023.
Article in English | MEDLINE | ID: covidwho-2236953

ABSTRACT

The coronavirus disease 2019 (COVID-19) pandemic had a transformational impact on public policy as governments played a leading role, working alongside and coordinating with business/industry, healthcare, public health, education, transportation, researchers, non-governmental organizations, philanthropy, and media/communications. This paper summarizes the impact of the pandemic on different areas of public policy affecting healthy living and cardiovascular health including prevention (i.e., nutrition, physical activity, air quality, tobacco use), risk factors for chronic disease (hypertension, diabetes, obesity, substance abuse), access to health care, care delivery and payment reform, telehealth and digital health, research, and employment policy. The paper underscores where public policy is evolving and where there are needs for future evidence base to inform policy development, and the intersections between the public and private sectors across the policy continuum. There is a continued need for global multi-sector coordination to optimize population health.


Subject(s)
COVID-19 , Humans , COVID-19/epidemiology , Delivery of Health Care , Obesity , Public Policy , Healthy Lifestyle
2.
Pediatrics ; 148(3)2021 09.
Article in English | MEDLINE | ID: covidwho-1295545

ABSTRACT

The coronavirus disease 2019 (COVID-19) pandemic led to an unprecedented demand for health care at a distance, and telehealth (the delivery of patient care using telecommunications technology) became more widespread. Since our 2018 state-of-the-art review assessing the pediatric telehealth landscape, there have been many changes in technology, policy, payment, and physician and patient acceptance of this care model. Clinical best practices in telehealth, on the other hand, have remained unchanged during this time, with the primary difference being the need to implement them at scale.Because of the pandemic, underlying health system weaknesses that have previously challenged telehealth adoption (including inequitable access to care, unsustainable costs in a fee-for-service system, and a lack of quality metrics for novel care delivery modalities) were simultaneously exacerbated. Higher volume use has provided a new appreciation of how patients from underrepresented backgrounds can benefit from or be disadvantaged by the shift toward virtual care. Moving forward, it will be critical to assess which COVID-19 telehealth changes should remain in place or be developed further to ensure children have equitable access to high-quality care.With this review, we aim to (1) depict today's pediatric telehealth practice in an era of digital disruption; (2) describe the people, training, processes, and tools needed for its successful implementation and sustainability; (3) examine health equity implications; and (4) critically review current telehealth policy as well as future policy needs. The American Academy of Pediatrics (AAP) is continuing to develop policy, specific practice tips, training modules, checklists, and other detailed resources, which will be available later in 2021.


Subject(s)
COVID-19/epidemiology , Pandemics , Telemedicine , Child , Health Equity , Humans , Patient Acceptance of Health Care , Practice Guidelines as Topic , Program Evaluation , Telemedicine/economics , Telemedicine/legislation & jurisprudence , Telemedicine/organization & administration , Telemedicine/trends
3.
J Am Med Inform Assoc ; 27(6): 963-966, 2020 06 01.
Article in English | MEDLINE | ID: covidwho-20452

ABSTRACT

The novel coronavirus disease 2019 infection poses serious challenges to the healthcare system that are being addressed through the creation of new unique and advanced systems of care with disjointed care processes (eg, telehealth screening, drive-through specimen collection, remote testing, telehealth management). However, our current regulations on the flows of information for clinical care and research are antiquated and often conflict at the state and federal levels. We discuss proposed changes to privacy regulations such as the Health Insurance Portability and Accountability Act designed to let health information seamlessly and frictionlessly flow among the health entities that need to collaborate on treatment of patients and, also, allow it to flow to researchers trying to understand how to limit its impacts.


Subject(s)
Betacoronavirus , Confidentiality/legislation & jurisprudence , Coronavirus Infections/epidemiology , Government Regulation , Health Information Exchange/legislation & jurisprudence , Pandemics , Pneumonia, Viral/epidemiology , COVID-19 , Communicable Disease Control , Contact Tracing/methods , Coronavirus Infections/prevention & control , Health Information Exchange/ethics , Health Insurance Portability and Accountability Act , Humans , Information Dissemination/legislation & jurisprudence , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Public Health Practice/legislation & jurisprudence , SARS-CoV-2 , United States
SELECTION OF CITATIONS
SEARCH DETAIL